- Filed
- Jul 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jul 14, 2025 | 16.83M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 14.45M sh |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 527.75K sh |
| Capex | Q1 2025 · Mar 31, 2025 | $9.91K |
| Capex | Q1 2025 · Mar 31, 2024 | $23.15K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$392.55K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$679.93K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $23.05K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $326.85K |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$637.64K |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$191.7K |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $2.39M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $2.59M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.44M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.64M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.69M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.75M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.75M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.23M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.05M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.55M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.08 |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$2.42 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$0.08 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$2.42 |
| Net Income | Q1 2025 · Mar 31, 2025 | −$1.2M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$1.28M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$971.52K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$1.03M |
| Gross Profit | Q1 2025 · Mar 31, 2025 | $91.64K |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | −$39.63K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $869.11K |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $1.1M |
| Revenue | Q1 2025 · Mar 31, 2025 | $960.76K |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $1.06M |